Literature DB >> 9249728

Allopurinol improves scavenging ability of the liver after ischemia/reperfusion injury.

W Karwinski1, O Søreide.   

Abstract

Deterioration of energy metabolism and oxidative stress represent fundamental mechanisms in ischemia and reperfusion injury. In a normothermic ischemia/reperfusion rat model, we investigated whether allopurinol (ALL) may improve the scavenging ability of the liver after ischemia. ALL was given prior to ischemia and reperfusion (concentration 100 or 50 mg/kg) and controls were given a placebo. After a basal period of 30 min, 1 h normothermic ischemia was induced in the median and left liver lobes followed by 24 h observation. The overall liver function was assessed by bile secretion, and free oxygen production was assessed by glutathione efflux into bile during the first 60 min of reperfusion and at 24 h. Allopurinol (concentration 100 mg/kg) protected hepatocyte function as bile flow improved significantly in this group after 1 and 24 h of reperfusion compared with that of controls. Oxidative stress was also significantly attenuated in this group, as efflux of glutathione into bile was significantly higher in the ALL group (100 mg/kg) after 24 h but not after 1 h of reperfusion compared with that of controls. All given in a concentration 50 mg/kg had some, but a non-significant, effect. We conclude that biliary glutathione is an important marker of oxidative stress and may reflect the scavenging ability of the liver after ischemic injury. Significant correlation of bile flow with biliary glutathione during reperfusion indicates that oxidative stress is an important mechanism attenuating liver function after ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9249728     DOI: 10.1111/j.1600-0676.1997.tb00796.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  The influence of allopurinol on kidney haemodynamic and excretory responses to renal ischaemia in anaesthetized rats.

Authors:  D Hestin; E J Johns
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

3.  The role of allopurinol's timing in the ischemia reperfusion injury of small intestine.

Authors:  Konstantinos Sapalidis; Theodossis S Papavramidis; Eleftherios Gialamas; Nikolaos Deligiannidis; Valentini Tzioufa; Spiros Papavramidis
Journal:  J Emerg Trauma Shock       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.